The post will be based in the Institute of Cognitive Neuroscience, an inter-disciplinary institute. The primary purpose of this PhD position is to conduct an experimental medicine study of a glutamatergic treatment for schizophrenia.
Application Deadline: 3rd June 2026
Further InformationPosted on 20/05/2026